These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17497760)

  • 61. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature.
    Ginsberg G; Hattis D; Sonawane B; Russ A; Banati P; Kozlak M; Smolenski S; Goble R
    Toxicol Sci; 2002 Apr; 66(2):185-200. PubMed ID: 11896285
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation.
    Walton K; Dorne JL; Renwick AG
    Food Chem Toxicol; 2001 Dec; 39(12):1175-90. PubMed ID: 11696391
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans.
    Walton K; Dorne JL; Renwick AG
    Food Chem Toxicol; 2004 Feb; 42(2):261-74. PubMed ID: 14667472
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human variability in glucuronidation in relation to uncertainty factors for risk assessment.
    Dorne JL; Walton K; Renwick AG
    Food Chem Toxicol; 2001 Dec; 39(12):1153-73. PubMed ID: 11696390
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment.
    Darney K; Turco L; Buratti FM; Di Consiglio E; Vichi S; Roudot AC; Béchaux C; Testai E; Dorne JLCM; Lautz LS
    Food Chem Toxicol; 2020 Jun; 140():111305. PubMed ID: 32234423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human variability and noncancer risk assessment--an analysis of the default uncertainty factor.
    Renwick AG; Lazarus NR
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):3-20. PubMed ID: 9629592
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A scoping review of evaluations of and recommendations for default uncertainty factors in human health risk assessment.
    Johanson G; Moto TP; Schenk L
    J Appl Toxicol; 2023 Jan; 43(1):186-194. PubMed ID: 36017531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance.
    Bhat VS; Meek MEB; Valcke M; English C; Boobis A; Brown R
    Crit Rev Toxicol; 2017 Oct; 47(9):729-749. PubMed ID: 28681680
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Refining
    Kasteel EEJ; Westerink RHS
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):1007-1017. PubMed ID: 33586568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates.
    Kulo A; de Hoon JN; Allegaert K
    Int J Pharm; 2012 Oct; 435(2):112-4. PubMed ID: 22641171
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Model systems and organisms for addressing inter- and intra-species variability in risk assessment.
    Rusyn I; Chiu WA; Wright FA
    Regul Toxicol Pharmacol; 2022 Jul; 132():105197. PubMed ID: 35636685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model.
    Tonnelier A; Coecke S; Zaldívar JM
    Arch Toxicol; 2012 Mar; 86(3):393-403. PubMed ID: 22089525
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Boron tolerable intake: re-evaluation of toxicokinetics for data-derived uncertainty factors.
    Dourson M; Maier A; Meek B; Renwick A; Ohanian E; Poirier K
    Biol Trace Elem Res; 1998; 66(1-3):453-63. PubMed ID: 10050937
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug Metabolism - From In Vitro to In Vivo, From Simple to Complex: Reflections of the BCPT Nordic Prize 2014 Awardee.
    Pelkonen O
    Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):147-55. PubMed ID: 26073298
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential sensitivity of children and adults to chemical toxicity. II. Risk and regulation.
    Dourson M; Charnley G; Scheuplein R
    Regul Toxicol Pharmacol; 2002 Jun; 35(3):448-67. PubMed ID: 12202058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effect of largactyl on tissue respiration. I. Oxygen consumption in hepatic and renal tissues].
    PERUZZO L; FORNI RB
    Minerva Anestesiol; 1953 Oct; 19(10):278-9. PubMed ID: 13132586
    [No Abstract]   [Full Text] [Related]  

  • 77. [Research on the urinary elimination of N-acetyl-p-aminophenol (NAPA) in newborn infants. II. Renal factors influencing the elimination of free NAPA and its conjugates].
    CAREDDU P; APOLLONIO T; PICENI-SERENI L; MEREU T
    Minerva Pediatr; 1962 Oct; 14():1047-9. PubMed ID: 14018621
    [No Abstract]   [Full Text] [Related]  

  • 78. A Dynamic Shift in Soil Metal Risk Assessment, It is Time to Shift from Toxicokinetics to Toxicodynamics.
    Renaud M; Sousa JP; Siciliano SD
    Environ Toxicol Chem; 2020 Jul; 39(7):1307-1308. PubMed ID: 32335927
    [No Abstract]   [Full Text] [Related]  

  • 79. PROBLEMS OF HUMAN VARIABILITY.
    Dodge R
    Science; 1924 Mar; 59(1525):263-70. PubMed ID: 17795453
    [No Abstract]   [Full Text] [Related]  

  • 80. Toxicokinetics of Bisphenol A - Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC).
    European Food Safety Authority (EFSA)
    EFSA J; 2008 Jul; 6(7):759. PubMed ID: 37213849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.